CCP
OGN icon

Corient Capital Partners’s Organon & Co OGN Stock Holding History

Corient Capital Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$254K Buy
+7,514
New +$227K 0.02% 517
2022
Q2 		– Sell
-6,878
Closed -$240K – 734
2022
Q1 		$240K Buy
+6,878
New +$235K 0.02% 625

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Corient Capital Partners's OGN Position: Q3 2022 in Review

Corient Capital Partners opened a new position in Organon & Co (OGN) in Q3 2022: 7,514 shares worth $254K. The stake represents 0.02% of the portfolio and ranks #517 among its holdings. This is a return to the name: Corient Capital Partners previously reported a position in OGN as recently as Q1 2022.

Corient Capital Partners first reported a position in OGN in Q1 2022 and has held it in 2 quarters since. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Corient Capital Partners held 7,514 shares of Organon & Co worth $254K as of Q3 2022.
  • Organon & Co was a new Corient Capital Partners position in Q3 2022.
  • Organon & Co made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #517 holding.
  • Corient Capital Partners first reported a position in Organon & Co in Q1 2022 and has held it in 2 quarters since.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.